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Abbreviations
and Acronyms
CPVT = catecholaminergic
polymorphic ventricular
tachycardia
CaMKII = Ca2þ/calmodulin-
dependent kinase II
DAD = delayed
afterdepolarizations
ECG = electrocardiogram
HF = heart failure
LV = left ventricular
NCX = Naþ/Ca2þ exchanger
PLB = phospholamban
RyR2 = cardiac ryanodine
receptor (type 2)
SERCA 2a = sarcoplasmic
reticulum Ca2þ-ATPase 2a
SR = sarcoplasmic reticulum
TAC = transverse aortic
constriction
WT = wild-type
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1570contractile dysfunction (2), re-
sulting in arrhythmias and HF, a
major cause for mortality in the
Western world (3).
Pressure overload–induced
changes that contribute to cardiac
remodeling include an increase in
the size of cardiomyocytes, alter-
ations in the extracellular matrix
with increased ﬁbrosis (4), and
abnormalities of the coronarySee page 1580vasculature (5). Development of
hypertrophy and its progression
to HF varies considerably be-
tween hypertensive individuals,
both in the magnitude of LV
mass increase and its geometric
pattern, such as chamber dilation
and wall thickening (6,7). How-ever, the mechanisms that modulate afterload-dependent
remodeling processes responsible for these interindividual
differences remain incompletely understood (8).
Altered cardiomyocyte Ca2þ homeostasis is a central
pathophysiological mechanism in hypertrophy and HF (9).
Disturbed intracellular Ca2þ handling accounts for abnor-
malities in Ca2þ signaling during excitation-contraction
coupling (10) and also for disturbances in maladaptive
gene expression and activation of many Ca2þ-dependent
hypertrophic signaling pathways (9). Dysfunction of the
cardiac ryanodine receptor (RyR2), the intracellular sarco-
plasmic reticulum (SR) Ca2þ release channel, is associated
with increased spontaneous diastolic SR Ca2þ release,
delayed afterdepolarizations (DADs), and triggered activity
(11). Consequently, contractile dysfunction and arrhythmias
occur in patients with hypertrophy and HF (12), and many
of these patients have hypertension as an underlying risk
factor or co-morbidity. Increased SR Ca2þ leak also occurs
in congenital arrhythmia syndromes associated with RyR2 or
calsequestrin mutations, such as catecholaminergic poly-
morphic ventricular tachycardia (CPVT) (13). CPVT is an
inherited arrhythmic disorder characterized by sudden car-
diac death during physical or emotional stress in the struc-
turally normal heart (13,14). However, the central role of
RyR2 in intracellular Ca2þ homeostasis makes it plausible
that even subtle abnormalities in RyR2 function may facil-
itate adverse cardiac remodeling. Therefore, we hypothe-
sized that dysfunctional SR Ca2þ release through mutated
RyR2 accelerates maladaptive LV remodeling under condi-
tions of pressure overload. We used a knock-in mouse model
carrying the RyR2R4496Cþ/– mutation associated with
increased diastolic SR Ca2þ leak and CPVT in humans to
test this hypothesis.In the present study, we show that constitutively abnormal
RyR2-mediated SR Ca2þ leak promotes myocardial
remodeling, including eccentric hypertrophy, dilation, and
contractile dysfunction, and increases mortality due to pump
failure in RyR2R4496Cþ/– mice under pressure overload.
Conversely, pharmacological stabilization of SR Ca2þ
release by K201 ameliorates the development of HF and
preserves systolic function.
Methods
An expanded version of the Methods section can be found
in the Online Appendix.
Heterozygous RyR2R4496Cþ/– knock-in mice (R4496C)
and their wild-type (WT) littermates underwent surgery
without (sham) or with transverse aortic constriction (TAC).
Dimensions and function of the left ventricle were assessed
by using transthoracic echocardiography (microimaging sys-
tem Vevo770, 30-MHz transducer, VisualSonics, Inc.,
Toronto, Ontario, Canada). Arrhythmias were continuously
monitored by using electrocardiogram (ECG) radio telem-
etry (DSI, St. Paul, Minnesota). The RyR2-stabilizing
agent K201 was administered via mini-osmotic pumps
(Alzet, DURECT Corporation, Cupertino, California).
Cardiomyocytes were isolated 1 week post-surgery as de-
scribed previously (15). [Ca2þ]i measurements were acquired
in line-scan mode by using a confocal microscope (LSM 510
Meta, Carl Zeiss Inc., Jena, Germany) using the solutions,
recording protocols, and analysis as described previously (16).
Data are shown as mean  SEM. Statistical differences
between groups were considered signiﬁcant when p < 0.05.
Results
Additional ﬁgures of the Results section can be found in the
Online Appendix.
Myocardial remodeling and ﬁbrosis. Increased afterload
on the left ventricle was induced by TAC (Fig. 1A). In WT
and R4496C mice, 1 week of TAC induced similar degrees
of cardiac hypertrophy as deﬁned by an increased heart
weight–to-tibia length (Fig. 1B). Three weeks’ post-TAC,
however, relative heart weight had increased signiﬁcantly
more in R4496C-TAC hearts compared with WT-TAC
hearts (11.3  0.7 mg/mm vs. 9.4  0.3 mg/mm; p < 0.05).
R4496C-TACmice had elevated lung weight–to-tibia length
ratio (5.7 0.6mg/mm; p< 0.05) compared withWT-TAC
mice (3.9  0.3 mg/mm) (Fig. 1C). Increased relative heart
weight correlated with induction of the hypertrophic gene
program (Figs. 1E and 1F), and activation of hypertrophic
genes was more prominent in R4496C-TAC hearts. Accel-
erated remodeling of R4496C-TAC hearts was associated
with more ﬁbrosis (compared with WT-TAC, p < 0.05)
(Figs. 1A and 1D) and increased myocyte length/width ratio
in isolated R4496C-TAC cardiomyocytes (Fig. 1G).
Accelerated progression from hypertrophy to HF.
R4496C-TAC mice underwent progressive LV chamber
dilation that started within the ﬁrst week after TAC
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Figure 1 Myocardial Remodeling and Fibrosis
(A) Photomicrographs of hearts (3 weeks post-surgery; top) and hematoxylin/eosin-stained (middle) and picrosirius red-stained (bottom) heart sections. (B) Heart weight/tibia
length ratio (HW/TL). (C) Lung weight/tibia length ratio (LW/TL) (N ¼ 13 to 24 mice). (D) Collagen content (N ¼ 8 to 10 mice). (E) Messenger ribonucleic acid levels of
b-myosin heavy chain (Myh7b). (F) Brain natriuretic peptide (Nppb) (N ¼ 6 to 8 mice). (G) Cell length-to-width ratio. Numbers in bars indicate the number of cardiomyocytes
measured (N ¼ 5 mice per group). TAC1 and TAC3 indicate 1 and 3 weeks after TAC, respectively. *p < 0.05 versus sham, #p < 0.05 versus wild-type (WT)-transverse aortic
constriction (TAC).
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1571(Figs. 2A and 2B). In contrast, WT-TAC mice effectively
compensated for pressure overload at 1 week after TAC with
moderate increases in LV end-diastolic diameter 3 weeks’
post-TAC. Increased dilation in conjunction with smaller
LV wall thickness suggest that R4496C-TAC hearts un-
derwent accelerated transition from load-induced hypertro-
phy to HF (Fig. 2B). Fractional shortening declined more in
R4496C-TAC hearts at 1 week (WT-TAC: –6.2  2.4%,
R4496C-TAC: –18.1  2.3%; p < 0.05) and 3 weeks post-
TAC (WT-TAC: –14.3  1.9%, R4496C-TAC: –23.9 
1.7; p < 0.05) (Fig. 2C). WT hearts responded with a
signiﬁcant increase in the relative wall thickness to pressure
overload. This physiological response was absent in
R4496C-TAC mice (compared with WT-TAC, p < 0.05)
(Fig. 2D). Eccentric LV remodeling in R4496C-TAC mice
was associated with premature death: only 36% of animals
were alive after 6 weeks of TAC compared with a 74%
survival rate in WT-TAC mice (p < 0.05) (Fig. 2E).
Impaired survival due to pump failure death in
R4496C-TAC mice. Susceptibility to catecholamine-
induced tachyarrhythmias and sudden cardiac death (17)could explain the increased mortality in R4496C-TAC
mice. ECG transmitters were implanted in a subset of
R4496C-TAC mice (n ¼ 11) to allow continuous recording
of ambulatory ECG waveforms. All of these 11 R4496C-
TAC mice, however, had sinus rhythm followed by pro-
gressing sinus bradycardia and atrioventricular conduction
block III, and they ultimately died of pump failure (Figs. 3A
and 3B1-3). In another set of experiments, we examined
whether R4496C-TAC mice were vulnerable to CPVT
under conditions that resemble those eliciting tachyar-
rhythmias in CPVT patients (14). Epinephrine and RyR2-
agonist caffeine administration increased heart rate and
induced sustained bidirectional ventricular tachycardia in
100% (6 of 6) of the R4496C-TAC survivors 1 week after
TAC (Fig. 3C). Persistent bidirectional ventricular tachy-
cardia induced by epinephrine/caffeine did not deteriorate
into bradycardia followed by asystole, but it subsided within
30 min and failed to induce sudden cardiac death in
100% (6 of 6) of the R4496C-TAC mice. These mice
developed progressive sinus bradycardia a few days later and
died thereafter of pump failure.
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Figure 2 Cardiac Remodeling, Function, and Survival
(A) Echocardiographic M-mode images of the left ventricle. (B) Sum of intraventricular septum (IVS) and posterior wall (PW) thickness plotted versus left ventricular end-diastolic
diameter (LVEDD) as an indicator for concentric versus dilative remodeling. R4496C-TAC mice (N ¼ 12 to 14) displayed accelerated transition from concentric hypertrophy to
dilation versus WT-TAC mice (N ¼ 15 to 21). (C) Systolic function indicated by fractional shortening (echocardiography) over time. (D) Relative left ventricular wall thickness,
indicating eccentric versus concentric remodeling, in R4496C-TAC and WT-TAC mice, respectively. (E) Kaplan-Meier survival curve. Number in parentheses indicates the number
of animals tested in each group. Dotted line represents 3 weeks post-TAC. *p < 0.05 versus sham, #p < 0.05 versus WT-TAC. Other abbreviations as in Figure 1.
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1572Increased SR Ca2D leak in R4496C-TAC mice. We
investigated whether pressure overload increases RyR2-
mediated SR Ca2þ leak measured as Ca2þ sparks (Fig. 4A).
Ca2þ spark frequency at matched SR Ca2þ load (Fig. 4B)
revealed a pronounced increase in SR Ca2þ leak in R4496C-
sham compared with WT-sham (173.6  20.9 pL–1s–1 and
102.2  9.7 pL–1s–1, respectively; p < 0.05) (Fig. 4C). Ca2þ
spark frequency at matched SR Ca2þ load was largely in-
creased in R4496C-TAC cardiomyocytes (332.7  42.9
pL–1s–1, p < 0.05) versus WT-TAC (190.1  27 pL–1s–1).
Impaired global Ca2D homeostasis. At baseline,
sham-operated WT and R4496C cardiomyocytes displayed
similar Ca2þ transients (Online Figs. 1A through 1D).
However, the peak of the caffeine-induced Ca2þ transient was
diminished in R4496C-sham cardiomyocytes versus WT-
sham cardiomyocytes (p < 0.05) (Online Fig. 1E). One week
after TAC, R4496C-TAC myocytes displayed signiﬁcantly
reduced peak amplitudes of Ca2þ transients, prolonged
[Ca2þ]i transient decline, and further reducedSRCa
2þ content
(all p < 0.05 vs. WT-TAC) (Online Figs. 1B, 1C, and 1E,
respectively).
Altered expression and phosphorylation of Ca2D regu-
latory proteins. Phosphorylation of RyR2 at Ser2808 and
at Ser2814 and also at Ser16 of PLB was unaltered in allgroups (Online Figs. 2A and 2B). However, phosphoryla-
tion of PLB at Thr17 was signiﬁcantly decreased in R4496C
(sham and TAC) mice (Online Fig. 2B). SERCA 2a levels
were reduced in both WT-TAC and R4496C-TAC hearts
compared with WT-sham hearts (p < 0.05) (Online
Fig. 2C). In contrast, Naþ/Ca2þ exchanger (NCX) expres-
sion was signiﬁcantly increased in R4496C-TAC mice only
but unchanged in WT-sham hearts (Online Fig. 2C).
Altered differential expression and phosphorylation of
CaMKII, calcineurin, and protein phosphatase 1. Under
baseline conditions, overall CaMKII expression and phos-
phorylation was similar, but the expression of CaMKIIg was
signiﬁcantly higher in R4496C compared with WT (Online
Fig. 2D). After 1 week of TAC, CaMKII expression and
phosphorylation were signiﬁcantly increased in both WT
and R4496C hearts. However, this increase was signiﬁcantly
higher in R4496C-TAC hearts (compared with WT-TAC
hearts, p < 0.05). Interestingly, the overall increase in
CaMKII after TAC was related to differential regulation
of its isoforms g and d. Whereas CaMKIIg was largely
increased after TAC in WT, CaMKIId remained un-
changed; in contrast, the smaller increase in CaMKIIg
in R4496C was associated with a parallel increase in
CaMKIId. Calcineurin protein levels signiﬁcantly increased
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Figure 3 Increased Mortality Due to Pump Failure Death in R4496C-TAC Mice
(A) Progressive decline in heart rate (HR) after TAC (the last 16 h before death shown by the inset). (B1 to B 3) Original electrocardiogram recordings from a R4496C-TAC mouse.
Note that sinus rhythm was followed by progressing sinus bradycardia and atrioventricular conduction block III. (C) Caffeine/epinephrine co-injection (arrow) increased the HR
and evoked nonlethal catecholaminergic polymorphic ventricular tachycardia episodes in R4496C-TAC mice (N ¼ 6). Insets show typical electrocardiogram recordings at various
time points. Other abbreviations as in Figure 1.
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1573with TAC in WT hearts but were already elevated in
R4496C hearts at baseline, with no further change after
TAC (Online Fig. 2E). Protein phosphatase 1 levels were
not affected by TAC but were up-regulated in both R4496C
groups (Online Fig. 2E).
K201 ameliorated the progression of HF and improved
survival in R4496C-TAC mice. Infusion of K201 resulted
in a mean K201 plasma concentration of 69.1  10.8 ng/ml
(n ¼ 6). After TAC, K201 prevented LV dilation (LV
end-systolic diameter) (Fig. 5A), prevented the decline in
fractional shortening (1week 6.6 2.6%; 3weeks 7.9 2.6%;
both p< 0.05 vs. control) (Fig. 5B), restored an increase in the
relative wall thickness (Fig. 5C), and largely prevented the
accelerated transition from concentric to eccentric remodeling
and LV dilation in R4496C-TAC mice (LV end-diastolic
diameter) (Fig. 5D). K201 treatment normalized survival
over 6 weeks after TAC (Fig. 5E). At 6 weeks, 83% of K201-
treated R4496C-TACmice were alive compared with 31% of
vehicle-treated mice (p < 0.05).
K201 prevented the spontaneous SR Ca2D release in
R4496C-TAC mice. To test whether the beneﬁcial effect
of K201 is related to a reduction in SR Ca2þ leak inR4496C-TAC cardiomyocytes, we assessed the effect of
K201 300 nmol/L and dantrolene 1 mmol/L (RyR2 stabi-
lizers) and KN-93 1 mmol/L (CaMKII inhibitor) on Ca2þ
spark frequency and global Ca2þ homeostasis. K201 and
dantrolene markedly reduced the increase in Ca2þ spark
frequency at matched SR Ca2þ load in R4496C-TAC and
WT-TAC cells as well as in R4496C-sham cells (Figs. 6A1-2
and 6B). The RyR2-stabilizing effect was more pronounced in
the presence of K201 than dantrolene. None of the RyR2-
channel stabilizers changed the peak Ca2þ transient ampli-
tude (Fig. 6C) and kinetics (data not shown) in TAC groups.
However, the peak of the caffeine-induced Ca2þ transient was
increased with K201 and dantrolene treatment in WT-TAC
and R4496C-TAC cells (Fig. 6D). In contrast to K201 and
dantrolene administration, KN-93 treatment did not signiﬁ-
cantly alter the Ca2þ spark frequency and global Ca2þ ho-
meostasis in any of the groups studied (Figs. 6A3 to 6D).
Discussion
In the present study, we demonstrated that the CPVT-
associated RyR2R4496Cþ/– gain-of-function mutation promotes
AB C
Figure 4 Ca2þ Spark Frequency
(A) Original confocal line-scan images. (B) Ca2þ spark frequency as a function of sarcoplasmic reticulum (SR) Ca2þ load (each symbol represents 1 cell). (C) Increased Ca2þ
spark frequency at matched SR Ca2þ content (box in B) showed elevated SR Ca2þ leak in R4496C-TAC. Numbers in bars indicate the number of cells tested 1 week after
surgery. *p < 0.05 versus respective sham, #p < 0.05 versus WT-TAC. Other abbreviations as in Figure 1.
Sedej et al. JACC Vol. 63, No. 15, 2014
Myocardial Remodeling in CPVT Mice April 22, 2014:1569–79
1574adverse structural and functional myocardial remodeling, HF,
and pump failure death in response to pressure overload. RyR2
stabilization by K201 attenuated the SR Ca2þ leak, ameliorated
the TAC-induced transition from hypertrophy to HF, and
improved survival of RyR2R4496Cþ/– mice.
Ca2D dysregulation and adverse remodeling. Increased
SR Ca2þ leak via RyR2 channels and reduced Ca2þ uptake
by SERCA 2a contribute to reduced SR Ca2þ content and
increased diastolic Ca2þ concentration in hypertrophy and
HF (18). RyR2R4496Cþ/– knock-in mice display increased SR
Ca2þ release (15) in structurally normal hearts, resulting in
increased diastolic Ca2þ concentration and catecholamine-
induced bidirectional tachycardias and ventricular ﬁbrillation
(14) similar to humans (13). Our results show that the
combination of pressure overload and dysregulated SR Ca2þ
release through mutated RyR2R4496Cþ/– channel promotes
rapid cardiac remodeling. A remarkable shift in the pattern
of hypertrophic remodeling related to increased SR Ca2þ
leak was reﬂected in altered gene expression, increasedﬁbrosis and relative heart weight, eccentric hypertrophy, and
LV dilation and dysfunction, which progressed into overt
HF. The involvement of RyR2-mediated SR Ca2þ release
for the development of pressure overload–induced hypertro-
phy has been recently demonstrated in RyR2R176Qþ/– knock-
in mice (19) and RyR2þ/–-deﬁcient mice (20). While
reduced SR Ca2þ release was associated with less concentric
hypertrophy and ﬁbrosis after 3 weeks of TAC (20), elevated
SR Ca2þ release via mutated channels of RyR2R176Qþ/–
enhanced the hypertrophic response accompanied by
impaired diastolic and systolic function and LV dilation by
activation of the calcineurin/NFAT-signaling pathway in
response to aortic constriction (19). Our study extends these
ﬁndings and provides evidence that the congenital RyR2
dysfunction promotes adverse myocardial remodeling, in-
cluding aggravation of RyR2-mediated SR Ca2þ leak and
altered intracellular Ca2þ handling, both of which may
contribute to the pronounced shift in phenotypic remodeling
during pressure overload.
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Figure 5 K201 Effect on R4496C-TAC Hearts
(A) K201 decreased left ventricular end-systolic diameter (LVESD), (B) improved fractional shortening, and (C) increased left ventricular wall thickness 1 week and 3 weeks
post-TAC in R4496C-TAC mice versus vehicle-treated R4496C-TAC mice. (D) K201 ameliorated the development of TAC-induced heart failure in R4496C mice (N ¼ 11)
compared with vehicle-treated R4496C-TAC mice (N ¼ 5 to 6). (E) Kaplan-Meier survival curve. Numbers in parentheses indicate the number of animals tested before and after 3
weeks TAC (dotted line). For comparison, baseline data from WT-TAC and R4496C-TAC mice are included (Fig. 2). *p < 0.05 versus K201-treated R4496C-TAC mice. xp < 0.05
versus vehicle-treated R4496C-TAC mice. Abbreviations as in Figure 1.
JACC Vol. 63, No. 15, 2014 Sedej et al.
April 22, 2014:1569–79 Myocardial Remodeling in CPVT Mice
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and before the transition to HF, the contribution of SERCA
2a to Ca2þ removal is reduced and already shifted in favor
of the NCX, and defective Ca2þ uptake into the SR is
partially compensated for by increased NCX expression (21).
In R4496C-TAC mice, this shift was reﬂected in re-
duced SR Ca2þ content, reduced peak amplitude of the
Ca2þ transient, and the prolonged [Ca2þ]i transient decline,
indicating decreased contractility and impaired relaxation,
respectively. Reduced SR Ca2þ content, a major cause for
contractile dysfunction in R4496C-TAC hearts, was asso-
ciated with the reduced SERCA 2a–dependent Ca2þ
removal, increased expression of NCX, and increased Ca2þ
spark frequency. These ﬁndings provide compelling evidence
for the pathophysiological relevance of dysfunctional SR
Ca2þ release in the dysregulation of SR Ca2þ handling,
which, in turn, provides the basis for the cardiomyocyte
malfunctioning associated with the development of pressure
overload–induced hypertrophy.
Increased expression and activity of CaMKII in R4496C
hearts at 1 week after aortic constriction suggest that an earlydevelopment of HF phenotype in R4496C-TAC mice is, at
least partially, attributed to the activation of CaMKII-
dependent hypertrophy pathways. This contrasts with the
study by van Oort et al. (19), in which the authors ruled out
the possible role of elevated SR Ca2þ leak in the activation
of CaMKII-dependent hypertrophy signaling. Recent
studies demonstrated that CaMKIId is required for alter-
ations in the expression of Ca2þ regulatory proteins during
the development of pressure overload–induced HF (22).
Conversely, CaMKIId deletion protects from adverse
remodeling after pressure overload (23) and progression
from pressure overload hypertrophy to HF (22). A disparity
in the expression between CaMKIIg and CaMKIId iso-
forms in R4496C-TAC hearts support the hypothesis that
increased expression of CaMKIId provoked early onset of
adverse myocardial remodeling. Up-regulation of CaMKIIdc
also contributes to abnormal Ca2þ handling and increased
mortality in R4496C mice (24). Notably, increased levels of
CaMKII did not affect the phosphorylation of RyR2 and
PLB in R4496C mice, likely due to increased PP1 levels.
Hence, our ﬁndings suggest that maladaptive CaMKII
A1 A2 A3
B
C
D
Figure 6 K201 Prevents SR Ca2þ Leak in R4496C Cardiomyocytes
(A1 to A3) Ca
2þ spark frequency as a function of SR Ca2þ content (each symbol represents 1 cell) in K201-, dantrolene- and KN-93–treated cells, respectively. (B) Ca2þ spark
frequency matched for SR Ca2þ load in K201-, dantrolene- and KN-93–treated cardiomyocytes. (C) Ca2þ transient peak amplitude and (D) SR [Ca2þ]i content. N¼ 10 to 45 cells per
treatment group were tested 1 week after sham/TAC. *p< 0.05 versus respectiveWT-sham treatment group, #p< 0.05 versus respectiveWT-TAC treatment group, xp< 0.05 versus
respective control group (white bars), zp < 0.05 versus respective K201-treated group, &p < 0.05 versus respective R4496C-sham. Abbreviations as in Figures 1 and 4.
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rather than functionally interfering with Ca2þ cycling. In
support of this hypothesis, we found that CaMKII inhibi-
tion with KN-93 did not attenuate Ca2þ spark frequency
and interfere with excitation-contraction coupling in the
absence of catecholaminergic stimulation in R4496C-TAC
cardiomyocytes, as described previously (17). Previous
studies emphasize the importance of CaMKII-mediated
phosphorylation of RyR2 in the progression of thenonischemic form of HF in both humans (12) and TAC
mice (25,26). However, our results suggest a minor role of
the CaMKII-mediated phosphorylation of RyR2 at Ser2814
on aberrant SR Ca2þ release via RyR2 and in vivo cardiac
dysfunction. This discrepancy may be related to different
time points at which the phosphorylation of RyR2 at
Ser2814 was assessed or the severity of cardiac decompen-
sation. In agreement with the study by van Oort et al. (19),
we found increased expression levels of calcineurin in
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WT), indicating the activation of the Ca2þ-dependent cal-
cineurin/NFAT hypertrophic signaling pathway.
Increased mortality and mode of death. Our study shows,
for the ﬁrst time, that pressure overload impairs the survival of
R4496C mice due to pump failure rather than ventricular
arrhythmias. Given that acute beta-adrenergic stimulation
predisposes R4496C mice to CPVT and ventricular ﬁbrilla-
tion (27), we anticipated that increased propensity for ven-
tricular arrhythmia was a major cause for increased mortality
in R4496C mice imposed to pressure overload. However,
even though R4496C-TAC cardiomyocytes exhibited an
increased arrhythmogenic potential in vitro, including
increased SR Ca2þ leak, reduced SERCA 2a–dependent
Ca2þ removal, and increased expression of NCX, ventricular
arrhythmias and sudden cardiac death were not observed
in vivo in R4496C mice under pressure overload. Several
reasons may account for this phenomenon, including reduced
SR Ca2þ content and beta-adrenergic responsiveness and the
absence of CaMKII-dependent phosphorylation of RyR2,
which has been shown to be required for arrhythmogenic
events leading to sudden cardiac death (24,25). Triggered
activity was effectively compensated for by reduced SR Ca2þ
load in the R4496C-TAC myocytes, such that the diastolic
SR Ca2þ leak was insufﬁcient to produce triggered activity
unless the SRCa2þ content was increased (28). In response to
beta-adrenergic stimulation, however, the R4496C mutation
results in largely increased SR Ca2þ leak and SR Ca2þ con-
tent due to increased CaMKII site-dependent RyR2 phos-
phorylation and increased SR Ca2þ re-uptake, respectively
(17). This has been related to an increased propensity to
DAD-mediated triggered activity underlying ventricular
tachyarrhythmia (27), which could also be elicited in our
R4496C-TAC hearts upon catecholamine stimulation.
Faster heart rate and SR Ca2þ uptake during adrenergic
stimulation increases SR Ca2þ load and induces subsequent
Ca2þ waves followed by DAD-mediated triggered beats in
ventricular cardiomyocytes harboring RyR2 mutations
(27,29). Notably, triggered activity in R4496C car-
diomyocytes also occurs with increasing SR Ca2þ content in
the absence of adrenergic stimulation (15). These ﬁndings
jointly highlight the importance of elevated SR Ca2þ content
as a principal trigger in the CPVT arrhythmogenesis.
Effects of pharmacological RyR2 stabilization on adverse
remodeling. Prevention of excessive diastolic RyR2-
mediated SR Ca2þ release with K201 suppresses SR Ca2þ
leak by stabilizing defective RyR2 gating (30) and improves
cardiac and skeletal muscle function in HF (31). Thus, use
of RyR2 stabilizers has been proposed as a therapeutic
strategy in patients with HF (31,32). We found that the
correction of dysfunctional Ca2þ release by chronic admin-
istration of K201 (plasma concentration w160 nmol/l)
ameliorated the development of eccentric dilation, improved
LV systolic function, and, most importantly, improved
survival of R4496C-TAC mice. The evidence that K201
decelerates the progression of HF in CPVT mice afterpressure overload extends previous ﬁndings, which demon-
strated that K201 improves contractile function in tissue
from end-stage human failing hearts (33) and delays the
progression of ventricular remodeling and dysfunction by
inhibiting the SR Ca2þ leak (31). Our in vitro experiments
demonstrated that K201 (at 300 nmol/L) and dantrolene
abolished acquired as well as congenital RyR2-mediated SR
Ca2þ leak to almost normal levels. Three ﬁndings conﬁrm
that K201 reduces RyR2 open probability in WT-TAC
and R4496C cells. First, K201 attenuated Ca2þ spark fre-
quency in all “diseased” groups. Second, K201 decreased
systolic [Ca2þ]i in R4496C-sham cells. Third, in WT- and
R4496C-TAC cardiomyocytes, K201 (and dantrolene)
increased the SR Ca2þ content and reduced fractional
release. This ﬁnding is consistent with our recent study (15),
in which we demonstrated that the dominant effect of K201
is RyR2 stabilization associated with reduced SR Ca2þ leak
in R4496C cells under conditions of similar and/or increased
SR Ca2þ content. Interestingly, K201 prevented SR Ca2þ
leak more effectively than dantrolene, implying that differ-
ences in the mode of interdomain interaction in those
different regions, to which K201 and dantrolene bind, may
result in the observed differences in their RyR2-stabilizing
efﬁcacy (34). Notably, K201 and dantrolene treatment did
not alter Ca2þ spark frequency and intracellular Ca2þ
handling in WT-sham cells, suggesting that both RyR2
stabilizers may be effective only in repairing defective
interdomain interactions of the RyR2. Our study showed
that the R4496C-TAC model has a much more complex
pathophysiology than the non-TAC CPVT model. There-
fore, the ﬁnding that K201 does not seem to prevent
arrhythmias in R4496C mice without TAC (27) may simply
mean that K201 acts on different pathways to eliminate store
overload–induced Ca2þ release (which is probably the reason
for arrhythmias in CPVT). Taken together, we found that
K201 and dantrolene suppressed SR Ca2þ leak by stabilizing
defective RyR2 gating, conﬁrming that destabilization of
RyR2 and consequent SR Ca2þ leak plays a pivotal role in
TAC-induced remodeling.
Potential clinical relevance. Our ﬁnding that increased
diastolic SR Ca2þ release is causally involved in the accel-
erated pathogenesis of pressure overload–induced HF has
important clinical implications. First, our study suggests that
patients with CPVT (with RyR2 mutations) that eventually
develop hypertension may be particularly vulnerable to the
development of eccentric hypertrophy and HF. Thus, it is
possible that CPVT patients present a “latent” substrate for
mechanical dysfunction that becomes overt with appropriate
triggers. This concept is corroborated by evidence for an
atypical form of cardiomyopathy reported in association with
some RyR2 mutations (35,36). Interestingly, genome-wide
association studies demonstrate that some RyR2 variants
(single nucleotide polymorphisms) increase susceptibility to
hypertension (37), indicating that aberrant RyR2 function
could represent an underlying pathogenic risk factor in heart
disease. Second, acquired imbalances of SR Ca2þ release are
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Many of these patients have hypertension as an underlying
risk factor or co-morbidity. This unfavorable combination
may underlie rapid progression of myocardial remodeling in
some of these patients and may partially explain interindi-
vidual differences in the pattern of remodeling (eccentric vs.
concentric hypertrophy).
Conclusions
In conditions of pressure overload, the gain-of-function
R4496C mutation in RyR2 accelerated the development
of congestive HF and increased mortality due to pump failure
rather than tachyarrhythmias. K201 attenuated the develop-
ment of HF and improved survival in these R4496C-TAC
mice. We suggest that RyR2-mediated SR Ca2þ leak con-
tributes to the myocardial remodeling under pressure over-
load. Our study proposes that RyR2 stabilizers may provide a
novel and rational approach to effectively combat hypertrophy
and development of HF in patients with hypertension and
acquired or congenital increased RyR2-mediated Ca2þ leak.
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APPENDIX
For and expanded Methods section and supplemental ﬁgures, please see
the online version of this article.
